While shRNAs have previously been used to knock down CXCR1 and CXCR2 in a human melanoma cell line showing inhibition of tumor growth and microvessel density, these experiments were performed in immune deficient mice and with only one cell line [50]. The gene discussed is CXCR2; the disease is neoplasm.